We serve Chemical Name:ethyl 5-oxo-1,2-dihydropyrazole-3-carboxylate CAS:40711-33-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl 5-oxo-1,2-dihydropyrazole-3-carboxylate
CAS.NO:40711-33-9
Synonyms:ethyl 5-hydroxypyrazole-3-carboxylate;ethyl 5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate;Pyrazolon-(5)-carbonsaeure-(3)-aethylester;3-Carboethoxy-5-Pyrazolinon;ethyl 5-hydroxy-1H-pyrazole-3-carboxylate;5-Oxo-2,5-dihydro-1H-pyrazol-3-carbonsaeure-aethylester;5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylic acid ethyl ester;5-Hydroxy-1H-pyrazole-3-carboxylic acid ethyl ester;3-Carbaethoxypyrazolin-5-on;ethyl 2,5-dihydro-5-oxo-1H-pyrazole-3-carboxylate
Molecular Formula:C6H8N2O3
Molecular Weight:156.13900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:75.21000
Exact Mass:156.05300
LogP:0.29200
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like ethyl 5-hydroxypyrazole-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 2,5-dihydro-5-oxo-1H-pyrazole-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Carbaethoxypyrazolin-5-on Use and application,5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylic acid ethyl ester technical grade,usp/ep/jp grade.
Related News: As a result, the team identified and prioritized studies that would provide the necessary product and process understanding needed to develop a control strategy, ensure the reproducibility of the product, and meet its intended safety, efficacy, stability, and performance profile regardless of the manufacturing scale. 2-[2-hydroxyethyl-[2-(5-nitrofuran-2-yl)quinazolin-4-yl]amino]ethanol manufacturers Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. 1-oxido-5,6,7,8-tetrahydroquinolin-1-ium suppliers As the Covid-19 pandemic continues to challenge the global drug supply chain, nations are looking for new ways to enable native producers to continue scaling up. Now, an Israeli API maker is dropping a down payment into an Indian intermediates company to ramp up its own manufacturing base. 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol vendor & factory.
